All supplements

Supplement evidence

051 / 575Mineral form

Magnesium glycinate

View my plan

The short answer

A well-tolerated magnesium form used to correct low intake; sleep-specific superiority is not established.

Evidence and scope
Conditional or population-specific

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Benefit depends on the population, formulation, baseline status, and objective; results should not be generalized.
Before deciding
Key concern: Separate from antibiotics and bisphosphonates; avoid unsupervised use with kidney impairment.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Meeting usual needs100–350 mg/day elemental magnesium

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFormulation-dependent

Not usefully classified as a fat- or water-soluble vitamin; absorption depends on the salt, extract, delivery system, and meal.

How it is commonly taken

Take with food if GI symptoms occur; dose by elemental magnesium, not compound weight.

Do not combine casually

Separate from antibiotics and bisphosphonates; avoid unsupervised use with kidney impairment.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

1research papers in this ledger
1unique primary studies represented
155unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2025
Mixed or qualifiedPMID 40918053 · DRKS00031494

Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep

Insomnia scores fell 3.9 points with bisglycinate and 2.3 with placebo; the between-group result was borderline (p=0.049) and small (d=0.2). Other psychological outcomes did not differ, and objective sleep was not measured.

Study design and methods
Design
Randomized, double-blind, placebo-controlled trial
Population
155 adults aged 18–65 with self-reported poor sleep
Intervention
Magnesium bisglycinate providing 250 mg elemental magnesium daily or placebo
Outcome
Insomnia Severity Index and psychological questionnaires

Funding or conflict note: One author directs a contract research organization that receives nutraceutical-company funding and has received nutraceutical presentation honoraria. This is the only directly formulation-specific trial located in this audit.

Open research record
Unscreened discovery appendix—not evidence4 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. The bioaccessibility and tolerability of marine-derived sources of magnesium and calcium.Dowley A, Long-Smith CM, Demehin O et al. · 2024 · Methods (San Diego, Calif.) · PMID 38608850Open on PubMed
  2. Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control: A randomized controlled clinical trial.Dall RD, Cheung MM, Shewokis PA et al. · 2023 · Nutrition research (New York, N.Y.) · PMID 36640582Open on PubMed
  3. The effect of combined magnesium and vitamin D supplementation on vitamin D status, systemic inflammation, and blood pressure: A randomized double-blinded controlled trial.Cheung MM, Dall RD, Shewokis PA et al. · 2022 · Nutrition (Burbank, Los Angeles County, Calif.) · PMID 35576873Open on PubMed
  4. Oral magnesium for relief in pregnancy-induced leg cramps: a randomised controlled trial.Supakatisant C, Phupong V · 2015 · Maternal & child nutrition · PMID 22909270Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.